- Home
- IR vs EW Comparison
IR vs EW Comparison
Compare IR & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IR
- EW
- Stock Information
- Founded
- IR 1859
- EW 1958
- Country
- IR United States
- EW United States
- Employees
- IR N/A
- EW N/A
- Industry
- IR Industrial Machinery/Components
- EW Industrial Specialties
- Sector
- IR Industrials
- EW Health Care
- Exchange
- IR Nasdaq
- EW Nasdaq
- Market Cap
- IR 34.2B
- EW 39.4B
- IPO Year
- IR N/A
- EW 2000
- Fundamental
- Price
- IR $72.05
- EW $71.52
- Analyst Decision
- IR Buy
- EW Buy
- Analyst Count
- IR 10
- EW 20
- Target Price
- IR $99.40
- EW $78.55
- AVG Volume (30 Days)
- IR 3.4M
- EW 4.9M
- Earning Date
- IR 05-01-2025
- EW 04-23-2025
- Dividend Yield
- IR 0.11%
- EW N/A
- EPS Growth
- IR 8.42
- EW 202.39
- EPS
- IR 2.06
- EW 6.97
- Revenue
- IR $7,235,000,000.00
- EW $5,439,500,000.00
- Revenue This Year
- IR $6.90
- EW $10.10
- Revenue Next Year
- IR $5.33
- EW $9.70
- P/E Ratio
- IR $34.98
- EW $10.28
- Revenue Growth
- IR 5.22
- EW 8.57
- 52 Week Low
- IR $65.61
- EW $58.93
- 52 Week High
- IR $106.03
- EW $95.25
- Technical
- Relative Strength Index (RSI)
- IR 39.94
- EW 53.89
- Support Level
- IR $70.76
- EW $65.94
- Resistance Level
- IR $74.36
- EW $73.26
- Average True Range (ATR)
- IR 3.72
- EW 2.43
- MACD
- IR 0.06
- EW 0.17
- Stochastic Oscillator
- IR 39.13
- EW 76.23
About IR Ingersoll Rand Inc.
Ingersoll Rand was formed through the merger of Gardner Denver and Ingersoll Rand's industrial segment. The firm's portfolio consists of two business lines: industrial technologies and services, and precision and science technologies. Ingersoll Rand serves a variety of end markets, including industrial, medical, and energy. Its broad portfolio of products includes compression, blower and vacuum, and fluid management. Ingersoll Rand generated roughly $7.2 billion in revenue in 2024.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.